GSK and Amgen. Thomas received a bachelor's degree from University of California, Los Angeles; a master's degree in ...
GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents, the ...
GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.
Irvine City Council backs out of plan for proposed homeless shelter The city of Irvine's plan to buy two properties on Armstrong Avenue was halted at the last minute in a 3-2 vote by council ...
Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Jack Smith will resign as special counsel before Donald Trump can fire him, several legal analysts have told Newsweek. Smith indicted Trump on four counts of allegedly working to interfere ...
It licensed the compound, an anti-CD20 mAb, to London-based GlaxoSmithKline in late 2006. The entire development process, from generating a hybridoma cell line to final approval, took seven years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback